Malignant hyperthermia due to anaesthesia (Q49249): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: T88.3 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 19:37, 13 August 2026
A condition caused by hypermetabolism in response to certain anaesthetic drugs. This condition is characterised by hyperthermia, tachycardia, tachypnoea, increased carbon dioxide production, increased oxygen consumption, acidosis, muscle rigidity, and rhabdomyolysis. This condition may be associated with genetic mutation.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | NE86 |
||
| English | Malignant hyperthermia due to anaesthesia |
A condition caused by hypermetabolism in response to certain anaesthetic drugs. This condition is characterised by hyperthermia, tachycardia, tachypnoea, increased carbon dioxide production, increased oxygen consumption, acidosis, muscle rigidity, and rhabdomyolysis. This condition may be associated with genetic mutation. |
Statements
CID11:NE86
0 references
dki-india-NE86
0 references
Concluído
0 references
13 August 2026
0 references
